"We remind investors that in Jan 2011 MannKind had received a second complete response letter (CRL) from the US Food and Drug Administration (:FDA) for Afrezza. The FDA had asked the company to conduct two phase III trials with the next-generation inhaler.
Last month MannKind completed its first phase III study (Study 171) on Afrezza in patients suffering from type I diabetes. "
I copied and pasted the above from an online article. The FDA asked mnkd to conduct two phase III trials and mnkd has only completed one for type I than when do they do the trials for type II and what impact will that have on the stock?
The second trial has been completed already. They were completed in May and June respectively. August is the delivery date for the results. Nice try but you're looking like a real amateur at this. Go crawl back under your rock and when you hear the earth trembling, that's the day the announcement will be heard by all and oh, what is causing the earth to tremble...that's the noise from all the shorts hitting the ground at one time when they hear how good the news will be. MNKD is also in advanced phase III trials in developing an inhaler supplied smelling salts for all the shorts that faint. This will definitely be a BLOCKBUSTER, OVER MILLIONS SERVED.
Right king mike. I also heard Al is blowing the meds into the patients with a straw. When will they make an inhaler? I read all two of your messages on the mknd board.. summary is that you are short and have weak skills compared to the much more dedicate losers you walk foolishly hand in hand with.